| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
the primary function of AI in the medical imaging industry is To improve diagnostic accuracy and patient outcomes because AI systems in medical imaging are designed to enhance the interpretation of medical images, aiding radiologists in detecting, diagnosing, and managing diseases more accurately and efficiently. These systems use machine learning algorithms to analyze imaging data, identify patterns, and provide diagnostic support, ultimately aiming to improve patient care and outcomes.
|
อ้างอิงจาก ABSTRACT https://www.sciencedirect.com/science/article/pii/S0933365723002129 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
A key benefit of AI in radiology noted in the article is Acts as a second medical opinion because AI in radiology can provide an additional layer of analysis and validation, offering a second opinion that helps radiologists in diagnosing and interpreting medical images more accurately. This assists in reducing diagnostic errors and improving overall patient care. |
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129
1. Introduction and motivation |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
According to the article, AI literacy refers to:
Understanding and knowledge of AI technology
AI literacy involves being knowledgeable about how AI technology works, its applications, and its implications. This understanding helps individuals and professionals navigate the complexities of AI systems and effectively integrate them into their fields, such as medical imaging |
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The factor is NOT listed as influencing the acceptability of AI among healthcare professionals is The color of the AI machines
|
Trust in AI systems: Healthcare professionals need to trust that AI systems are reliable and accurate.
Integration of AI with existing workflows: AI tools must fit smoothly into current medical practices and workflows.
System understanding: Users need to understand how AI systems work and how to interpret their results.
Technology receptiveness: The general openness and willingness of healthcare professionals to adopt new technologies.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
The role does social influence play in AI acceptability in healthcare according to the article is Affects healthcare professionals’ decisions to use AI
|
Social influence can impact how healthcare professionals perceive and decide to adopt AI technologies in their practice.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
The a perceived threat regarding AI usage in healthcare settings is Concerns about replacing healthcare professionals |
This concern reflects anxiety about AI potentially displacing human jobs and reducing the need for healthcare professionals, which can impact the dynamics of healthcare delivery and employment.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129
https://www.techtarget.com/healthtechanalytics/feature/Exploring-Patient-Provider-Perceptions-of-Healthcare-AI
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
The essential for increasing AI acceptability among medical professionals is Designing human-centred AI systems |
This approach ensures that AI systems are developed with a focus on the needs, preferences, and working conditions of healthcare professionals, which can enhance their acceptance and effective integration into medical practice.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0290613 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
This category focuses on how well the AI system integrates into existing medical workflows and its perceived value to users in their everyday tasks.
|
system usage is The extent to which healthcare professionals view the use of AI as providing
meaningful value to their work (e.g. improving task productivity and/or
diagnostic accuracy)
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality impact AI acceptability among healthcare professionals is Affects views on AI based on compatibility with professional values
|
Healthcare professionals are more likely to accept AI systems if they align with their ethical standards and professional values. This ensures that the AI tools are used responsibly and in ways that uphold the integrity of patient care and professional practices.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129
https://www.sciencedirect.com/science/article/pii/S1078817423002584 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Future studies should take a comprehensive approach by exploring how AI systems integrate with existing workflows and addressing user experience to enhance the acceptability and effectiveness of AI in healthcare settings. |
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S0933365723002129
https://www.sciencedirect.com/science/article/pii/S2772503024000136
https://www.sciencedirect.com/science/article/pii/S1078817423002584 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson's disease is characterized by the loss of dopamine-producing neurons in the brain. Human embryonic stem cells have the potential to differentiate into dopamine neurons, which can help replace those lost due to the disease and restore normal function.
|
Parkinson's disease causes the loss of dopaminergic neurons. These neurons help release and regulate dopamine, which plays a key role in many different bodily functions, especially those involving movement, thinking, motivation, and mood. Stem cell therapy aims to replace the failing dopaminergic neurons
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
https://www.medicalnewstoday.com/articles/stem-cell-therapy-for-parkinsons |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
Animal was used to test the STEM-PD product for safety and efficacy is rats
STEM-PD, a cell therapy product developed for Parkinson’s disease, underwent testing in non-human primates to assess its safety and efficacy before advancing to human clinical trials. |
Safety. Large safety studies in rats with STEM-PD cells have shown that the cells are safe; they maintained long-term within the site of transplantation with no signs of distribution to other sites in the body; no signs of toxicity; and no tumour formation.
https://stem-pd.org/about-stem-pd/
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
The duration of the preclinical safety study in rats mentioned in the article was 6 months. |
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The name of the clinical trial phase mentioned for STEM-PD is Phase I/IIa. |
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
https://nyscf.org/resources/a-nyscf-supported-cell-therapy-for-parkinsons-disease-is-entering-clinical-trials/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is manufactured under GMP-compliant conditions.
|
The human pluripotent stem cells used for generating the STEM-PD product come from human embryonic stem cells, grown in the laboratory from a surplus embryo from in vitro fertilisation
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
https://stem-pd.org/about-stem-pd/
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The safety of the STEM-PD product in rats was confirmed by there being no adverse effects or tumor formation. |
To confirm the safety of the STEM-PD product in rats, the study found that there were no adverse effects or tumor formation. This result indicates that the product was considered safe based on the preclinical testing conducted.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
In the efficacy study of STEM-PD in rats, the key finding was that transplanted cells reversed motor deficits in rats. This indicates that the treatment was effective in addressing motor function issues associated with Parkinson's disease in the animal model. |
The key finding noted in the efficacy study of STEM-PD in rats was that transplanted cells reversed motor deficits in rats. This indicates that the STEM-PD treatment was effective in improving motor functions in the animal model used for the study.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
To assess the purity of the STEM-PD batch, the specific markers used were GIRK2 and ALDH1A1. These markers are associated with the identification of dopamine neurons, which are crucial for evaluating the purity and functionality of the stem cell-derived product. |
In the article, the specific markers used to assess the purity of the STEM-PD batch are GIRK2 and ALDH1A1. These markers are critical for confirming the presence of dopamine neurons, which is essential for evaluating the effectiveness and purity of the stem cell-derived product.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
In the manufacturing process of STEM-PD, growth factors like FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) are used in cell patterning for specific neural fates. These growth factors play a crucial role in directing the differentiation of stem cells into specific types of neurons, particularly dopamine neurons, which are necessary for the efficacy of the STEM-PD product.
|
The role of growth factors like FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) in the manufacturing process of STEM-PD is to be used in cell patterning for specific neural fates. These factors are critical for guiding the differentiation of stem cells into the desired type of neurons, specifically dopamine-producing neurons, which are essential for the therapeutic efficacy of the STEM-PD product.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622657/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
In the preclinical trials for efficacy of STEM-PD in rats, a key outcome measured was the recovery of motor function. The trials aimed to evaluate whether the transplanted cells could improve motor deficits typically associated with conditions like Parkinson's disease.
|
In the study on STEM-PD, the key outcome measured in the preclinical trials for efficacy in rats was recovery of motor function. This outcome was assessed to determine the effectiveness of the transplanted cells in improving motor deficits associated with neurodegenerative conditions, such as Parkinson's disease.
อ้างอิงจาก https://www.sciencedirect.com/science/article/pii/S1934590923003211
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.15902 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|